Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, NMDA subunit 2B (GluN2B, NR2B) is a subunit of the NMDA receptor, an ionotropic glutamate receptor. It plays a crucial role in synaptic plasticity, learning, memory, and neural development. Alterations in GRIN2B, the gene encoding GluN2B, are associated with intellectual disability, neuropsychiatric conditions, and stroke.
Voltage-dependent channel block (Mg²⁺), Allosteric inhibition (Zn²⁺), Allosteric modulation (Polyamines), Selective antagonism (Ifenprodil)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA subunit 2B (None).